Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Saturday, January 09, 2010

Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antia

Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds.

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.